| Product Code: ETC7615279 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Iraq Patented Drugs Market Overview |
3.1 Iraq Country Macro Economic Indicators |
3.2 Iraq Patented Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Iraq Patented Drugs Market - Industry Life Cycle |
3.4 Iraq Patented Drugs Market - Porter's Five Forces |
3.5 Iraq Patented Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.6 Iraq Patented Drugs Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
3.7 Iraq Patented Drugs Market Revenues & Volume Share, By Indication, 2021 & 2031F |
4 Iraq Patented Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in Iraq |
4.2.2 Government initiatives to improve healthcare infrastructure |
4.2.3 Growing awareness and demand for patented drugs in the market |
4.3 Market Restraints |
4.3.1 High cost associated with patented drugs limiting affordability |
4.3.2 Limited access to healthcare services in certain regions of Iraq |
4.3.3 Regulatory challenges and delays in drug approvals |
5 Iraq Patented Drugs Market Trends |
6 Iraq Patented Drugs Market, By Types |
6.1 Iraq Patented Drugs Market, By Distribution Channel |
6.1.1 Overview and Analysis |
6.1.2 Iraq Patented Drugs Market Revenues & Volume, By Distribution Channel, 2021- 2031F |
6.1.3 Iraq Patented Drugs Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.1.4 Iraq Patented Drugs Market Revenues & Volume, By Drug Store and Retail Pharmacies, 2021- 2031F |
6.1.5 Iraq Patented Drugs Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.2 Iraq Patented Drugs Market, By Dosage Form |
6.2.1 Overview and Analysis |
6.2.2 Iraq Patented Drugs Market Revenues & Volume, By Solid Drug Product, 2021- 2031F |
6.2.3 Iraq Patented Drugs Market Revenues & Volume, By Liquid Drug Product, 2021- 2031F |
6.2.4 Iraq Patented Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Iraq Patented Drugs Market, By Indication |
6.3.1 Overview and Analysis |
6.3.2 Iraq Patented Drugs Market Revenues & Volume, By Cardiovascular Diseases, 2021- 2031F |
6.3.3 Iraq Patented Drugs Market Revenues & Volume, By Cancer, 2021- 2031F |
6.3.4 Iraq Patented Drugs Market Revenues & Volume, By Autoimmune Diseases, 2021- 2031F |
6.3.5 Iraq Patented Drugs Market Revenues & Volume, By Others, 2021- 2031F |
7 Iraq Patented Drugs Market Import-Export Trade Statistics |
7.1 Iraq Patented Drugs Market Export to Major Countries |
7.2 Iraq Patented Drugs Market Imports from Major Countries |
8 Iraq Patented Drugs Market Key Performance Indicators |
8.1 Number of patents filed and granted for new drugs in Iraq |
8.2 Investment in research and development for patented drugs |
8.3 Number of partnerships between local and international pharmaceutical companies for technology transfer and licensing |
8.4 Percentage of healthcare professionals prescribing patented drugs based on clinical guidelines |
8.5 Patient adherence and compliance rates with patented drug therapies |
9 Iraq Patented Drugs Market - Opportunity Assessment |
9.1 Iraq Patented Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.2 Iraq Patented Drugs Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
9.3 Iraq Patented Drugs Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 Iraq Patented Drugs Market - Competitive Landscape |
10.1 Iraq Patented Drugs Market Revenue Share, By Companies, 2024 |
10.2 Iraq Patented Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here